IL61649A0 - Derivatives of cyclic peptide nuclei - Google Patents

Derivatives of cyclic peptide nuclei

Info

Publication number
IL61649A0
IL61649A0 IL61649A IL6164980A IL61649A0 IL 61649 A0 IL61649 A0 IL 61649A0 IL 61649 A IL61649 A IL 61649A IL 6164980 A IL6164980 A IL 6164980A IL 61649 A0 IL61649 A0 IL 61649A0
Authority
IL
Israel
Prior art keywords
derivatives
cyclic peptide
peptide nuclei
nuclei
cyclic
Prior art date
Application number
IL61649A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/181,438 external-priority patent/US4320052A/en
Priority claimed from US06/181,444 external-priority patent/US4320053A/en
Priority claimed from US06/181,450 external-priority patent/US4322338A/en
Priority claimed from US06/181,451 external-priority patent/US4320054A/en
Priority claimed from US06/181,445 external-priority patent/US4287120A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL61649A0 publication Critical patent/IL61649A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62Streptosporangium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL61649A 1979-12-13 1980-12-05 Derivatives of cyclic peptide nuclei IL61649A0 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US10313079A 1979-12-13 1979-12-13
US10331579A 1979-12-13 1979-12-13
US10331479A 1979-12-13 1979-12-13
US10303079A 1979-12-13 1979-12-13
US10331679A 1979-12-13 1979-12-13
US06/181,438 US4320052A (en) 1979-12-13 1980-08-25 Derivatives of A-30912A nucleus
US06/181,444 US4320053A (en) 1979-12-13 1980-08-25 Derivatives of A-30912D nucleus
US06/181,450 US4322338A (en) 1979-12-13 1980-08-25 Derivatives of A-30912B nucleus
US06/181,451 US4320054A (en) 1979-12-13 1980-08-25 Derivatives of A-30912H nucleus
US06/181,445 US4287120A (en) 1979-12-13 1980-08-25 Derivatives of S31794/F-1 nucleus

Publications (1)

Publication Number Publication Date
IL61649A0 true IL61649A0 (en) 1981-01-30

Family

ID=27581001

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61649A IL61649A0 (en) 1979-12-13 1980-12-05 Derivatives of cyclic peptide nuclei

Country Status (11)

Country Link
EP (1) EP0031662A1 (pt)
CA (1) CA1182812A (pt)
DD (1) DD155178A5 (pt)
DK (1) DK528180A (pt)
FI (1) FI803870L (pt)
FR (1) FR2479207A1 (pt)
GB (1) GB2065663A (pt)
IL (1) IL61649A0 (pt)
IT (1) IT1141132B (pt)
PT (1) PT72152A (pt)
YU (1) YU310880A (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057724A1 (en) * 1980-08-15 1982-08-18 Sandoz Ag New metabolites, processes for their production and their use
US4703042A (en) * 1984-05-21 1987-10-27 Bodor Nicholas S Orally active heparin salts containing multivalent cationic units
EP0294990A3 (en) * 1987-06-10 1990-05-09 Eli Lilly And Company Chromatographic purification process
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product
EP0311193B1 (en) * 1987-10-07 1993-12-01 Merck & Co. Inc. Antifungal fermentation product
NZ234225A (en) * 1989-06-30 1993-09-27 Merck & Co Inc Antibiotic from zalerion arboricola and its use as an antifungal agent and antipneumocystis agent
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
DK0438813T3 (da) * 1990-01-26 1998-07-27 Hoechst Ag Nyt antibiotikum, deoxymulundocandin, en fremgangsmåde til dets fremstilling samt dets anvendelse som lægemiddel
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them
GB9506372D0 (en) * 1995-03-29 1995-05-17 Fujisawa Pharmaceutical Co New peptide compounds
US20040082757A1 (en) * 2001-02-26 2004-04-29 Katsuhiko Ito Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742435A1 (de) * 1976-09-28 1978-04-06 Sandoz Ag Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung

Also Published As

Publication number Publication date
DD155178A5 (de) 1982-05-19
DK528180A (da) 1981-06-14
FR2479207A1 (fr) 1981-10-02
PT72152A (en) 1981-01-01
IT8026631A0 (it) 1980-12-12
CA1182812A (en) 1985-02-19
YU310880A (en) 1983-02-28
GB2065663A (en) 1981-07-01
FI803870L (fi) 1981-06-14
IT1141132B (it) 1986-10-01
EP0031662A1 (en) 1981-07-08

Similar Documents

Publication Publication Date Title
GB2048852B (en) Derivatives of glycinamide
EG12981A (en) Substituted acy derivatives of amino acids
DE2962923D1 (en) Preparation of n-substituted derivatives of 1-deoxy-nojirimycine
GR63092B (en) Preparation process of untriakonta peptides
AU2912777A (en) Cyclic peptide derivatives
JPS5366491A (en) Fixing of protein
GR62565B (en) Preparation process of peptides
IL61648A0 (en) Derivatives of cyclic peptide nuclei
IL61649A0 (en) Derivatives of cyclic peptide nuclei
GB2065131B (en) Cyclic peptide nuclei
NZ183733A (en) Preparation of 1-n-substituted-kanamycins
JPS52156811A (en) Derivatives of dipeptide
IL61650A0 (en) Derivatives of cyclic peptice nuclei
ZA807815B (en) Derivatives of cyclic peptide nuclei
GB1541427A (en) Preparation of hydroxysulphobetaines
JPS52142072A (en) Preparation of perfluoroo44oxoo2*55dimethyll 22fluorocarbonyll1*33dioxolan
ZA807817B (en) Derivatives of cyclic peptide niclei
JPS5283914A (en) Improvement of galenus medicine
JPS5610473A (en) Structure of printingghammer
ZA807816B (en) Cyclic peptide nuclei
AU6533580A (en) Derivatives of cyclic peptide nuclei
AU6533480A (en) Derivatives of cyclic peptide nuclei
AU6533380A (en) Derivatives of cyclic peptide nuclei
IE802609L (en) Derivatives of cyclic peptide nuclei
IE802607L (en) Derivatives of cyclic peptide nuclei